Tecovirimat Treatment for Monkeypox Virus Keratouveitis

Luciana P S Finamor; Denise de Freitas; Gabriel Andrade; Víctor D Bergamasco; Laura Cunha; Carolina Lázari; Cristina Muccioli

doi:10.1001/jamaophthalmol.2022.5486

Tecovirimat Treatment for Monkeypox Virus Keratouveitis

JAMA Ophthalmol. 2023 Feb 1;141(2):210-212. doi: 10.1001/jamaophthalmol.2022.5486.

Authors

Luciana P S Finamor^{1

2

3}, Denise de Freitas¹, Gabriel Andrade^{1

2

3

4}, Víctor D Bergamasco^{1

2

3}, Laura Cunha^{2

3}, Carolina Lázari^{3

5}, Cristina Muccioli¹

Affiliations

¹ Department of Ophthalmology and Visual Sciences, Paulista School of Medicine, Federal University of São Paulo, São Paulo, Brazil.
² Moacir Cunha Eye Clinic, São Paulo, Brazil.
³ Fleury Group, São Paulo, Brazil.
⁴ Department of Ophthalmology, Santa Casa de São Paulo, São Paulo, Brazil.
⁵ Molecular Biology Laboratory University of São Paulo, School of Medicine, São Paulo, Brazil.

PMID: 36547989
DOI: 10.1001/jamaophthalmol.2022.5486

No abstract available

Plain language summary

This case report describes tecovirimat treatment for a patient with monkeypox virus–related keratouveitis.

MeSH terms

Antiviral Agents* / therapeutic use
Humans
Monkeypox virus*
Mpox (monkeypox)* / complications
Mpox (monkeypox)* / drug therapy
Uveitis* / drug therapy
Uveitis* / etiology

Substances

tecovirimat
Antiviral Agents